Home
/
Marker Therapeutics, Inc.
/
Financials
/
Quarterly
Marker Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Marker Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$0
Nov 12, 2019
Q2
2019
Jun 30, 2019
$0
Aug 9, 2019
Q3
2019
Sep 30, 2018
$0
Nov 12, 2019
Q2
2019
Jun 30, 2018
$206.0K
Aug 9, 2019
Q3
2018
Sep 30, 2017
$183.1K
Nov 13, 2018
Q2
2018
Jun 30, 2017
$0
Aug 9, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.00M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($4.02M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($4.45M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.31M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($2.19M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.39M)
May 15, 2025
Q3
2024
Sep 30, 2023
($2.98M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
$2.52M
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.97M)
May 15, 2024
Q3
2023
Sep 30, 2022
($6.92M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($9.24M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($9.91M)
May 15, 2023
Q3
2022
Sep 30, 2021
($12.43M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($10.91M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($8.78M)
May 13, 2022
Q3
2021
Sep 30, 2020
($7.37M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($6.34M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($6.49M)
May 12, 2021
Q3
2020
Sep 30, 2019
($5.46M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($5.57M)
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.14M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($4.26M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($4.61M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.40M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($2.31M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.55M)
May 15, 2025
Q3
2024
Sep 30, 2023
($3.20M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.13M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.31M)
May 15, 2024
Q3
2023
Sep 30, 2022
($5.83M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($5.27M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($9.79M)
May 15, 2023
Q3
2022
Sep 30, 2021
($10.02M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($10.91M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($8.78M)
May 13, 2022
Q3
2021
Sep 30, 2020
($7.38M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($6.36M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($6.64M)
May 12, 2021
Q3
2020
Sep 30, 2019
($5.65M)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($5.87M)
Aug 10, 2020